Showing results (331-340 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|February 1, 2005
Racial differences in serum lipids in HIV+ women treated with protease inhibitor regimensLinda L Bausserman, Karen T Tashima, Melissa DiSpigno, et al.
HIV Clinical Trials|August 2, 2006
Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trialsAlan R Lifson, Frank S Rhame, Waldo H Belloso, et al.
HIV Clinical Trials|June 27, 2006
Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophyMichel Duong, Jean Michel Petit, Benoit Martha, et al.
HIV Clinical Trials|June 27, 2006
Serious renal impairment occurs rarely with use of tenofovir DFJames D Scott, Peter R Wolfe, Robert K Bolan, et al.
HIV Clinical Trials|June 27, 2006
Evaluation of Subcutaneous Proleukin (interleukin-2) in a Randomized International Trial (ESPRIT): geographical and gender differences in the baseline characteristics of participantsS L Pett, H Wand, M G Law, et al.
HIV Clinical Trials|November 25, 2003
Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapyPablo Barreiro, Carmen de Mendoza, Nuria Camino, et al.
HIV Clinical Trials|November 25, 2003
Analysis of undetectable HIV RNA using survival analysis: results must be interpreted carefullyRodolphe Thiébaut, Hélène Jacqmin-Gadda, Valérie Journot, et al.
HIV Clinical Trials|August 14, 2003
Replacement of protease inhibitors by nevirapine or efavirenz in simplification and rescue interventions: which works better?Pablo Barreiro, Nuria Camino, Rosa De Julián, et al.
HIV Clinical Trials|August 14, 2003
Sustained efficacy of nevirapine in combination with two nucleoside analogues in the treatment of HIV-infected patients: a 48-week retrospective multicenter studyP S Allan, J Arumainayagam, V Harindra, et al.
HIV Clinical Trials|August 14, 2003
Efficacy and tolerance of HCV treatment in HIV-HCV coinfected patients: the potential interaction of PI treatmentI Poizot-Martin, C Marimoutou, S Benhaim, et al.
Pageof 68